Fabian Gerlinghaus from Cellares explains how automation, closed systems, and global manufacturing networks could transform cell therapy from a niche treatment to a widely accessible medicine.
Source: The Scientist Atom Feed
You might be interested in …
Make Every Voice Count This Earth Day
We all have the power to protect our planet, this month and beyond.
Exploring a Lab-in-the-Loop System for Antibody Design
Discover how the latest approach to linear DNA expression workflows can streamline antibody design processes.
‘Forbidden Planet’ at 70: Why the original sci-fi blockbuster is still out of this world
The movie that took Shakespeare to the stars, and wrote the blueprint for movie space opera.
